COVID-19 Policies
Issuance Date Title
Department Circular 2021-0374 August 26, 2021 Price Cap for COVID-19 Reverse Transcriptions-Polymerase Reaction (RT-PCR) Testing
Department Circular 2021-0375 August 24, 2021 Reiteration of functions of Infectious Control Committees in health facilities and modification of staffing patterns and further clarification of the shortening of quarantine for the healthcare workers
Department Memorandum 2021-0287 June 18, 2021 Guidelines for the Management and administration of COVID-19 mRNA Vaccine (Nucleoside Modified) Moderna COVID-19 Vaccine
Joint Memorandum Circular 2021-0001 June 03, 2021 Procedures on the Procurement and Distribution of COVID-19 Vaccines for Private Entities
Department Memorandum 2021-0259 May 31, 2021 Implementing Guidelines for Priority Groups A4, A5 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines
Department Memorandum 2021-0223 May 06, 2021 Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum 2021-0197 April 19, 2021 Updated Suggested Retail Price (SRPs) for Emergency Essential Medicines and Medical Devices due to the Coronavirus Disease 2019 (COVID-19) Health Event
Department Memorandum 2021-0175 April 08, 2021 Further Clarification on the National Deployment and Vaccination Plan for COVID-19 Vaccines and Additional Guidelines for Sinovac Implementation
Department Circular 2021-0122 April 05, 2021 Reiteration of Prevention, Detection, Isolation, Treatment, and Reintegration (PDITR) Strategies for COVID-19 in Light of the Implementation of Enhance Community Quarantine in NCR Plus Bubble
Department Circular 2021-0118 March 31, 2021 Continuity of Operations of Private COVID-19 Testing Laboratories during the Observance of the Holy Week
Department Memorandum 2021-0161 March 31, 2021 Interim Guidelines for the Conduct of Saliva-Based RT-PCR Testing for the Detection of SARS Cov-2
Department Memorandum 2021-0157 March 30, 2021 Implementing Guidelines for Priority Group A3 and Further Clarification of the National Deployment and Vaccination Plan for COVID-19 Vaccines

Pages